))
Author interviews that explore the latest clinical reviews.
…
continue reading
A geriatrics and palliative care podcast for every health care professional. We invite the brightest minds in geriatrics, hospice, and palliative care to talk about the topics that you care most about, ranging from recently published research in the field to controversies that keep us up at night. You'll laugh, learn and maybe sing along. Hosted by Eric Widera and Alex Smith. CME available!
…
continue reading
Each week, renowned editor-in-chief of the Journal of the American College of Cardiology (JACC), Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition, as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the ...
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
Interviews with authors of Care at the Close of Life reviews in JAMA about management issues in end of life and palliative care. JAMAevidence is an evidence-based medicine (EBM) resource created and maintained by the JAMA Network to promote the use of EBM to improve patient care.
…
continue reading
1
Stepped Palliative Care: A Podcast with Jennifer Temel, Chris Jones, and Pallavi Kumar
50:17
50:17
Play later
Play later
Lists
Like
Liked
50:17
If palliative care was a drug, one question we would want to know before prescribing it is what dose we should give. Give too little - it may not work. Give too much, it may cause harm (even if the higher dose had no significant side effects, it would require patients to take a lot of unnecessary additional pills as well as increase the cost.) So, …
…
continue reading
1
Diagnosis and Treatment of Community-Acquired Pneumonia (CAP)
22:55
22:55
Play later
Play later
Lists
Like
Liked
22:55
Community-acquired pneumonia is associated with approximately 740 000 hospitalizations and 41 000 deaths in the US annually. JAMA Review authors Scott A. Flanders, MD, and Valerie M. Vaughn, MD, MSc, discuss diagnosis and treatment of community-acquired pneumonia with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Community-Acquired…
…
continue reading
1
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update: A Report of the American College of Cardiology ...
6:10
6:10
Play later
Play later
Lists
Like
Liked
6:10
In the September 24, 2024, JACC issue, Dr. Valentin Fuster presents the latest expert consensus on heart failure management, updating the 2019 guidelines with ten key changes. Highlights include a strong emphasis on SGLT inhibitors throughout hospitalization and a refined approach to managing heart failure patients, ensuring timely adjustments in t…
…
continue reading
In this episode, Dr. Valentin Fuster highlights key studies from the September 24, 2024 issue of JACC, featuring groundbreaking research on the impact of cold temperatures on myocardial infarctions, the nuanced recovery process in Takotsubo syndrome, and evolving trends in the condition. Also discussed are novel insights into predicting long-term o…
…
continue reading
1
Recovery of Left Ventricular Function and Long-term Outcomes in Patients with Takotsubo Syndrome
12:09
12:09
Play later
Play later
Lists
Like
Liked
12:09
In the September 24, 2024 issue of JACC, Dr. Manuel Almendro Odelia and Dr. Ivan Nunet Hill present groundbreaking research on Takotsubo syndrome, revealing that delayed recovery of left ventricular function significantly worsens both short and long-term survival. The study, based on data from the extensive RITACCO registry, identifies key predicto…
…
continue reading
1
Interactions of Sleep Apnea with the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review
25:36
25:36
Play later
Play later
Lists
Like
Liked
25:36
In this episode, Dr. Valentin Fuster dives into a comprehensive review of obstructive sleep apnea, exploring its complex interactions with cardiovascular disease and discussing its multifaceted treatment options. The podcast unpacks how sleep apnea exacerbates cardiovascular conditions through biological pathways, examines the impact of various the…
…
continue reading
1
Predicting Long-term Clinical Outcomes of Patients with Recurrent Pericarditis
10:04
10:04
Play later
Play later
Lists
Like
Liked
10:04
In the September 24, 2024, issue of JACC, Dr. Abdullah Yashin Yaprak and his team at Cleveland Clinic unveil a groundbreaking risk prediction model for recurrent pericarditis using machine learning. Their study, analyzing data from 365 patients, offers a novel tool to stratify patients based on their likelihood of achieving clinical remission, show…
…
continue reading
1
Temporal Trends in Takotsubo Syndrome - Results from the International Takotsubo Registry
10:07
10:07
Play later
Play later
Lists
Like
Liked
10:07
In the September 24, 2024 issue of JACC, Dr. Valentin Fuster explores a pivotal study on Takotsubo Syndrome, revealing significant shifts in patient demographics, trigger types, and outcomes over nearly two decades. The research highlights an increase in physical triggers and short-term mortality, reflecting a more complex and severe understanding …
…
continue reading
1
Short-term effects of lower air temperature and cold spells on myocardial infarction hospitalizations in Sweden
13:22
13:22
Play later
Play later
Lists
Like
Liked
13:22
In the September 24, 2024 issue of JACC, Dr. Ben Lee Nay and colleagues reveal that short-term exposures to lower temperatures and cold spells significantly increase the risk of myocardial infarction hospitalizations in Sweden. This nationwide study, utilizing advanced machine learning techniques, underscores the pressing need to address both extre…
…
continue reading
1
Well-being and Resilience: a Podcast with Jane Thomas, Naomi Saks, Ishwaria Subbiah
50:50
50:50
Play later
Play later
Lists
Like
Liked
50:50
Well-being and resilience are so hot right now. We have an endless supply of CME courses on decreasing burnout through self-care strategies. Well-being committees are popping up at every level of an organization. And C-suites now have chief wellness officers sitting at the table. I must admit, though, sometimes it just feels off… inauthentic, as if…
…
continue reading
1
Scabies, Bedbug, and Body Lice Infestations
18:41
18:41
Play later
Play later
Lists
Like
Liked
18:41
Infestations by ectoparasites such as scabies, bedbugs, and body lice are common. Diagnosis requires history, including social drivers of health such as living environment, and physical examination. Author Aileen Y. Chang, MD, MSPH, of UCSF, joins JAMA Senior Editor Karen Lasser, MD, to discuss Scabies, Bedbug, and Body Lice Infestations: A Narrati…
…
continue reading
1
Adverse Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea and Obesity: Metabolic Surgery versus Usual Care
12:06
12:06
Play later
Play later
Lists
Like
Liked
12:06
In this episode, Dr. Valentin Fuster reviews a groundbreaking study comparing metabolic surgery to traditional care for patients with obesity and obstructive sleep apnea. The research shows that metabolic surgery significantly lowers the risk of major cardiovascular events and mortality, highlighting the need for a multifaceted approach to treating…
…
continue reading
1
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
10:33
10:33
Play later
Play later
Lists
Like
Liked
10:33
In the September 17, 2024 issue of JACC, Valentin Fuster discusses a study on sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, which shows modest improvements in health status among patients with worsening heart failure. While the study highlights sotagliflozin's benefits, it also points out gaps in understanding its full impact and emphasizes the …
…
continue reading
1
Effect of Evogliptin on the Progression of Aortic Valvular Calcification
10:45
10:45
Play later
Play later
Lists
Like
Liked
10:45
In the September 17, 2024 issue of JACC, Dr. Jai Quan Song and colleagues explore whether the DPP-4 inhibitor, abrogating, can slow the progression of aortic valvular calcification. Although the primary endpoint was not met, the study's promising secondary results and ongoing research into related therapies suggest potential future breakthroughs in…
…
continue reading
1
Prognostic value of plasma IgG N-glycome traits in pulmonary arterial hypertension
10:56
10:56
Play later
Play later
Lists
Like
Liked
10:56
In this September 17, 2024 JACC issue, Dr. Zhi Jian Zhang and colleagues unveil a groundbreaking study on pulmonary arterial hypertension (PAH) that identifies plasma IgG fucosylation and glycan traits as promising prognostic markers. This research not only enhances survival predictions beyond current models but also opens intriguing possibilities …
…
continue reading
In this episode, Valentin Fuster reviews the September 17, 2024, JACC issue, highlighting pivotal studies on metabolic surgery's impact on cardiovascular risk in obstructive sleep apnea patients, and the potential of DPP-4 inhibitors in aortic valve calcification. He also discusses the benefits of Sitagliptin for heart failure and the prognostic va…
…
continue reading
1
Genotype Guided Antiplatelet Therapy: JACC Review Topic of the Week
12:11
12:11
Play later
Play later
Lists
Like
Liked
12:11
In this episode of JACC, Valentin Fuster examines genotype-guided antiplatelet therapy, emphasizing its potential to tailor treatments based on genetic variants for improved patient outcomes. While promising, the approach faces challenges like testing delays and variable patient responses that need addressing for broader implementation.…
…
continue reading
Dr. Marcus Anker, presenting at ESC, discussed the RESHAPE HF2 trial's findings on transcatheter edge-to-edge repair for secondary mitral regurgitation, published in JACC with Aakriti Gupta, MD, FACC, JACC Executive Associate Editor.
…
continue reading
Pericarditis accounts for up to 5% of emergency department visits for nonischemic chest pain in North America and Western Europe. JAMA Review author Paul C. Cremer, MD, MS, discusses the recommended treatments for acute pericarditis and more with JAMA Associate Editor David L. Simel, MD, MHS. Related Content: Diagnosis, Risk Stratification, and Tre…
…
continue reading
1
Effect of Screening for Undiagnosed Atrial Fibrillation and on Stroke Prevention | ESC Congress
14:18
14:18
Play later
Play later
Lists
Like
Liked
14:18
Xiaoxi Yao, MPH, MS, PhD, FACC, JACC Associate Editor, interviews Renato Lopes, MD, PhD, FACC, author of the GUARD-AF trial published in JACC and presented at ESC Congress 2024.
…
continue reading
1
Allowing Patients to Die: Louise Aronson and Bill Andereck
49:03
49:03
Play later
Play later
Lists
Like
Liked
49:03
In today’s podcast we set the stage with the story of Dax Cowart, who in 1973 was a 25 year old man horribly burned in a freak accident. Two thirds of his body was burned, most of his fingers were amputated, and he lost vision in both eyes. During his 14 month recovery Dax repeatedly demanded that he be allowed to die. The requests were ignored. Af…
…
continue reading
1
Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
21:47
21:47
Play later
Play later
Lists
Like
Liked
21:47
Michelle M. Kittleson, MD, PhD, FACC, JACC Associate Editor and John A. Spertus, MD, MPH, FACC discuss the evaluation of the cardiac myosin inhibitor, aficamten, on patient-reported health status in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) as part of the SEQUOIA trial. The study utilized the Kansas City Cardiomyopathy…
…
continue reading
1
Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood
10:05
10:05
Play later
Play later
Lists
Like
Liked
10:05
In the September 10, 2024, JACC issue, Dr. Valentin Fuster highlights a pivotal study showing that a single cholesterol measurement in young adults can predict future cardiovascular risk with remarkable accuracy. He underscores the need for early lipid screening and novel long-acting treatments to improve long-term cardiovascular health, stressing …
…
continue reading
